—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Immunovant Inc (IMVT) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 31 out of 100 (momentum 55 · quality 1 · valuation 5), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +8.6% vs the 50-day and +10.9% vs the 200-day average, 21.4% below the 52-week high and +66.6% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Immunovant Inc trades 8.6% above its 50-day and 10.9% above its 200-day moving average. (as of 2026-11-10)

Immunovant is a clinical-stage biotechnology company that develops antibody therapies for autoimmune diseases. Its main candidate blocks the neonatal receptor that recycles antibodies in the body, a mechanism aimed at conditions such as Graves' disease, myasthenia gravis and lupus-related skin disease.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the IMVT overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +8.6% vs the 50-day and +10.9% vs the 200-day average, 21.4% below the 52-week high and +66.6% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the IMVT chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on IMVT?

Uptrend stack intact — Trades +8.6% vs the 50-day and +10.9% vs the 200-day average, 21.4% below the 52-week high and +66.6% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is IMVT above its 50-day and 200-day moving averages?

As of 2026-11-10, Immunovant Inc trades +8.6% above its 50-day and +10.9% above its 200-day average, with the 20-day +21.7% away.

How far is IMVT from its 52-week high?

21.4% below the 52-week high and 66.6% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.